Eli Lilly is switching its employee drug benefit plan from CVS Health to Rightway, a move reportedly linked to CVS's decision to stop covering Lilly's weight-loss drug Zepbound in favor of Novo Nordisk's Wegovy. Lilly stated the change was due to Rightway offering competitive fees and services aligned with employee interests.